Previous 10 | Next 10 |
2023-08-31 06:24:00 ET 3 Things To Use to Become a Successful Penny Stocks Trader Trading penny stocks has garnered significant attention in recent years, primarily due to their potential for substantial returns on investment. At their core, penny stocks are shares of companies that...
2023-08-31 03:30:52 ET Summary Baker Brothers' 13F portfolio value decreased from $18.38B to $17.28B. The largest five stakes in the portfolio are Seagen, Incyte, BeiGene, ACADIA Pharmaceuticals, and Madrigal Pharmaceuticals, making up around 83% of the portfolio. Baker Brothe...
2023-08-30 13:16:02 ET Gainers: NanoVibronix ( NAOV ) +127% . iCoreConnect ( ICCT ) +49% . Aravive ( ARAV ) +35% . AEON Biopharma ( AEON ) +33% . Alarum Technologies ( ALAR ) +25% . Greenland Technologies Holding Corporation ...
2023-08-22 16:09:27 ET Aravive sinks amid downgrades after Phase 3 setback for lead asset Aravive stock pops on FDA orphan drug status for batiraxcept to treat pancreatic cancer Aravive gains on FDA Fast Track status for lead program Aravive to raise $41.5M in di...
2023-08-03 13:02:58 ET Gainers: Bluejay Diagnostics ( BJDX ) +73% . T2 Biosystems ( TTOO ) +67% . Traeger ( COOK ) +41% . Upwork ( UPWK ) +41% . Adamis Pharmaceuticals Corporation ( ADMP ) +40% . Motorsport Games ( MSGM )...
2023-08-03 10:16:24 ET Gainers: Bluejay Diagnostics ( BJDX ) +74% . Adamis Pharmaceuticals ( ADMP ) +59% . T2 Biosystems ( TTOO ) +47% . Community Health Systems ( CYH ) +18% . Cyclo Therapeutics ( CYTH ) +17% . Losers:...
2023-08-03 09:05:43 ET Aravive ( ARAV ) -58% announces top-line results from phase 3 AXLerate-OC study of batiraxcept in patinum-resistant ovarian cancer. Vicarious Surgical ( RBOT ) -41% on pricing $45M offering . DXC Technology Company ( DXC ) -24% ...
2023-08-03 08:52:55 ET More on Aravive Aravive: Very Small Company With Late Stage Trial In Ovarian Cancer Aravive stock pops on FDA orphan drug status for batiraxcept to treat pancreatic cancer Aravive gains on FDA Fast Track status for lead program Aravive ...
Trial did not meet primary endpoint of progression-free survival Cash at the end of Q2 of approximately $18M (unaudited) is expected to be sufficient to fund operations into early Q4 2023 HOUSTON, Aug. 02, 2023 (GLOBE NEWSWIRE) -- Aravive, Inc. (Nasdaq: ARAV, “the Company”...
2023-07-28 14:00:40 ET Welcome to Seeking Alpha's Catalyst Watch - a breakdown of some of next week's actionable events that stand out. Check out Saturday morning's regular Stocks to Watch article for a full list of events planned for the week or the Seeking Alpha earnings calendar ...
News, Short Squeeze, Breakout and More Instantly...
Amerityre Corp (AMTY) is expected to report for Q3 2024 CURO Group Holdings Corp. (CUROQ) is expected to report for Q1 2024 China Health Industries Holdings Inc (CHHE) is expected to report for Q3 2024 Avid Bioservices Inc. (CDMO) is expected to report $0.03 for Q4 2024 Anterix In...
Blue Ridge Real Estate Co. (BRRE) is expected to report for Q2 2024 Aravive Inc. (ARAV) is expected to report for Q1 2024 Biocept Inc. (BIOCQ) is expected to report for Q1 2024 Golden Matrix Group Inc. (GMGI) is expected to report for Q2 2024 Bluejay Diagnostics Inc. (BJDX) is exp...
SunPower Corporation (SPWR) is expected to report $-0.29 for Q1 2024 Siemens Healthineers AG ADR (SMMNY) is expected to report for Q2 2024 Specificity Inc Com (SPTY) is expected to report for Q1 2024 Tokyo Gas Co. Ltd. ADR (TKGSY) is expected to report for Q4 2024 Gol Linhas Aerea...